MedTrace Logo

Penile Intracavernosal Stem Cells Therapy for Erectile Dysfunction

NCT02665520 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-01-27

No results posted yet for this study

Summary

Autologous Fat Derived Stem Cell treatment of ED.

To assess safety and primary efficacy of stem cell infusion in refractory ED.

To investigate the success rate and durability of success of using this new therapy in management of moderate and sever cases of erectile dysfunction.

Conditions

Interventions

PROCEDURE

liposuction for retrieval of own stem cells from fat cells

Sponsors & Collaborators

  • King Saud University

    collaborator OTHER

  • Elaj medical centers

    lead OTHER

Principal Investigators

  • Saleh Binsaleh, MD · King Saud University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • Saudi Arabia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665520 on ClinicalTrials.gov